Lauterbach A - Search Results

1

Design and synthesis of 1,5- and 2,5-substituted tetrahydrobenzazepinones as novel potent and selective integrin alphaVbeta3 antagonists.

Kling A, Backfisch G, Delzer J, Geneste H, Graef C, Hornberger W, Lange UE, Lauterbach A, Seitz W, Subkowski T. Kling A, et al. Among authors: lauterbach a. Bioorg Med Chem. 2003 Apr 3;11(7):1319-41. doi: 10.1016/s0968-0896(02)00616-8. Bioorg Med Chem. 2003. PMID: 12628659

2

Synthesis and SAR of N-substituted dibenzazepinone derivatives as novel potent and selective alpha(V)beta(3) antagonists.

Kling A, Backfisch G, Delzer J, Geneste H, Graef C, Holzenkamp U, Hornberger W, Lange UE, Lauterbach A, Mack H, Seitz W, Subkowski T. Kling A, et al. Among authors: lauterbach a. Bioorg Med Chem Lett. 2002 Feb 11;12(3):441-6. doi: 10.1016/s0960-894x(01)00773-9. Bioorg Med Chem Lett. 2002. PMID: 11814816

3

Synthesis of highly potent and selective hetaryl ureas as integrin alpha(V)beta3-receptor antagonists.

Lange UE, Backfisch G, Delzer J, Geneste H, Graef C, Hornberger W, Kling A, Lauterbach A, Subkowski T, Zechel C. Lange UE, et al. Among authors: lauterbach a. Bioorg Med Chem Lett. 2002 May 20;12(10):1379-82. doi: 10.1016/s0960-894x(02)00161-0. Bioorg Med Chem Lett. 2002. PMID: 11992781

4

Highly potent and selective alphaVbeta3-receptor antagonists: solid-phase synthesis and SAR of 1-substituted 4-amino-1H-pyrimidin-2-ones.

Zechel C, Backfisch G, Delzer J, Geneste H, Graef C, Hornberger W, Kling A, Lange UE, Lauterbach A, Seitz W, Subkowski T. Zechel C, et al. Among authors: lauterbach a. Bioorg Med Chem Lett. 2003 Jan 20;13(2):165-9. doi: 10.1016/s0960-894x(02)00931-9. Bioorg Med Chem Lett. 2003. PMID: 12482416

5

[Long version on the S3 guidelines for axial spondyloarthritis including Bechterew's disease and early forms, Update 2019 : Evidence-based guidelines of the German Society for Rheumatology (DGRh) and participating medical scientific specialist societies and other organizations].

Kiltz U, Braun J; DGRh; Becker A; DEGAM; Chenot JF, Dreimann M; DWG; Hammel L; DVMB; Heiligenhaus A; DOG; Hermann KG; DRG; Klett R; DGMM; Krause D, Kreitner KF, Lange U; DGPMR/DGRW; Lauterbach A; Physio Deutschland; Mau W, Mössner R; DDG; Oberschelp U; DGOOC; Philipp S, Pleyer U, Rudwaleit M, Schneider E, Schulte TL, Sieper J, Stallmach A; DGIM; Swoboda B; DGOOC/DGORh; Winking M; DGNC. Kiltz U, et al. Among authors: lauterbach a. Z Rheumatol. 2019 Dec;78(Suppl 1):3-64. doi: 10.1007/s00393-019-0670-3. Z Rheumatol. 2019. PMID: 31784900 German. No abstract available.

6

[Development of quality standards for patients with rheumatoid arthritis for use in Germany].

Kiltz U, Buschhorn-Milberger V, Albrecht K, Lakomek HJ, Lorenz HM, Rudwaleit M, Schneider M, Schulze-Koops H, Aringer M, Hasenbring MI, Herzer P, von Hinüber U, Krüger K, Lauterbach A, Manger B, Oltman R, Schuch F, Schmale-Grede R, Späthling-Mestekemper S, Zinke S, Braun J. Kiltz U, et al. Among authors: lauterbach a. Z Rheumatol. 2022 Nov;81(9):744-759. doi: 10.1007/s00393-021-01093-1. Epub 2021 Oct 15. Z Rheumatol. 2022. PMID: 34652486 Free PMC article. German.

7

Cysteine-binding adjuvant enhances survival and promotes immune function in a murine model of acute myeloid leukemia.

Slezak AJ, Chang K, Beckman TN, Refvik KC, Alpar AT, Lauterbach AL, Solanki A, Kwon JW, Gomes S, Mansurov A, Hubbell JA. Slezak AJ, et al. Among authors: lauterbach al. Blood Adv. 2024 Apr 9;8(7):1747-1759. doi: 10.1182/bloodadvances.2023012529. Blood Adv. 2024. PMID: 38324726 Free PMC article.

8

Synthetically mannosylated antigens induce antigen-specific humoral tolerance and reduce anti-drug antibody responses to immunogenic biologics.

Wallace RP, Refvik KC, Antane JT, Brünggel K, Tremain AC, Raczy MR, Alpar AT, Nguyen M, Solanki A, Slezak AJ, Watkins EA, Lauterbach AL, Cao S, Wilson DS, Hubbell JA. Wallace RP, et al. Among authors: lauterbach al. Cell Rep Med. 2024 Jan 16;5(1):101345. doi: 10.1016/j.xcrm.2023.101345. Epub 2023 Dec 20. Cell Rep Med. 2024. PMID: 38128533 Free PMC article.

9

Can welfare states buffer technostress? Income and technostress in the context of various OECD countries.

Lauterbach AS, Tober T, Kunze F, Busemeyer MR. Lauterbach AS, et al. PLoS One. 2023 Dec 5;18(12):e0295229. doi: 10.1371/journal.pone.0295229. eCollection 2023. PLoS One. 2023. PMID: 38051751 Free PMC article.

10

Author Correction: Topically-applied collagen-binding serum albumin-fused interleukin-4 modulates wound microenvironment in non-healing wounds.

Lauterbach AL, Wallace RP, Alpar AT, Refvik KC, Reda JW, Ishihara A, Beckman TN, Slezak AJ, Mizukami Y, Mansurov A, Gomes S, Ishihara J, Hubbell JA. Lauterbach AL, et al. NPJ Regen Med. 2023 Nov 2;8(1):62. doi: 10.1038/s41536-023-00338-8. NPJ Regen Med. 2023. PMID: 37919358 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters